Pacer Advisors, Inc. Atreca, Inc. Transaction History

Pacer Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$7.82 - $13.8 $7,014 - $12,378	-897 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$13.0 - $19.34 $2,392 - $3,558	-184 Reduced 17.02%	897 $14,000
Q4 2020 Jan 20, 2021	BUY	$13.03 - $17.09 $14,085 - $18,474	1,081 New	1,081 $17,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.